speb/financial-data huggingface dataset:
TCBI income_statement (quarterly, 2025-09-30) — Interest Expense: 188844000.00
TCBI income_statement (quarterly, 2025-09-30) — Interest Income: 460615000.00
TCBI cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 193604000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3957514000.00
TCBI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -245666000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 4601654000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 620416000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 620416000.00
TCBI cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
TCBI cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -7076000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Income: 105210000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 100897000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 105210000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 105210000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 105210000.00
TCBI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 105210000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 105210000.00
TCBI income_statement (quarterly, 2025-09-30) — Net Interest Income: 271771000.00
TCBI cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 39353000.00
TCBI cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -975000000.00
TCBI cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
TCBI balance_sheet (quarterly, 2025-09-30) — Net PPE: 88348000.00
TCBI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -4950000.00
TCBI cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -975000000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3635602000.00
TCBI income_statement (quarterly, 2025-09-30) — Normalized Income: 105210000.00
TCBI income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 11828000.00
TCBI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 166295000.00
TCBI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -700000.00
TCBI income_statement (quarterly, 2025-09-30) — Operating Revenue: 340354000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 45679863.00
TCBI balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 0.00
TCBI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -84224000.00
TCBI income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 37807000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3801261000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Payables: 9360000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9360000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 300000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 300000000.00
TCBI cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -4313000.00
TCBI income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 4313000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 300000000.00
TCBI income_statement (quarterly, 2025-09-30) — Pretax Income: 137779000.00
TCBI cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -646000.00
TCBI income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 12474000.00
TCBI cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -143138000.00
TCBI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -4950000.00
TCBI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 12622000.00
TCBI cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
TCBI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -7076000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2712298000.00
TCBI income_statement (quarterly, 2025-09-30) — Salaries And Wages: 119856000.00
TCBI cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 182491000.00
TCBI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 3412000.00
TCBI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 128466000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Share Issued: 51767419.00
TCBI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 8237000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3637098000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3335602000.00
TCBI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TCBI income_statement (quarterly, 2025-09-30) — Tax Provision: 32569000.00
TCBI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
TCBI balance_sheet (quarterly, 2025-09-30) — Total Assets: 32536980000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4257514000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Total Debt: 620416000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3637098000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 28899882000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Trading Securities: 2219000.00
TCBI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 6087556.00
TCBI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 361076000.00
TCBI income_statement (annual, 2025-12-31) — +Total Revenue: 1255779000.00
TCBI income_statement (quarterly, 2025-12-31) — +Total Revenue: 327483000.00
TCBI balance_sheet (annual, 2025-12-31) — Accounts Payable: 6716000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 6716000.00
TCBI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -43685000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -43685000.00
TCBI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1074496000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1074496000.00
TCBI balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 3993453000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 3993453000.00
TCBI income_statement (annual, 2025-12-31) — Basic Average Shares: 45625948.00
TCBI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 45021963.00
TCBI income_statement (annual, 2025-12-31) — Basic EPS: 6.86
TCBI income_statement (quarterly, 2025-12-31) — Basic EPS: 2.14
TCBI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3188808000.00
TCBI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 3064825000.00
TCBI cash_flow (annual, 2025-12-31) — Capital Expenditure: -12569000.00
TCBI balance_sheet (annual, 2025-12-31) — Capital Stock: 300518000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 300518000.00
TCBI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2099118000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2099118000.00
TCBI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 2099118000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 2099118000.00
TCBI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -17250000.00
TCBI cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -4312000.00
TCBI balance_sheet (annual, 2025-12-31) — Cash Financial: 201315000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Cash Financial: 201315000.00
TCBI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 404269000.00
TCBI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1132364000.00
TCBI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1854113000.00
TCBI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 36163000.00
TCBI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 360154000.00
TCBI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 130494000.00
TCBI cash_flow (annual, 2025-12-31) — Change In Account Payable: -68921000.00
TCBI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2638000.00
TCBI cash_flow (annual, 2025-12-31) — Change In Payable: -68921000.00
TCBI cash_flow (quarterly, 2025-12-31) — Change In Payable: -2638000.00
TCBI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -68921000.00
TCBI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2638000.00
TCBI cash_flow (annual, 2025-12-31) — Change In Receivables: -57773000.00
TCBI cash_flow (quarterly, 2025-12-31) — Change In Receivables: -17824000.00
TCBI cash_flow (annual, 2025-12-31) — Change In Working Capital: -126694000.00
TCBI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -20462000.00
TCBI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -57773000.00
TCBI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -17824000.00
TCBI cash_flow (annual, 2025-12-31) — Changes In Cash: -1089690000.00
TCBI cash_flow (quarterly, 2025-12-31) — Changes In Cash: -965707000.00
TCBI balance_sheet (annual, 2025-12-31) — Common Stock: 518000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Common Stock: 518000.00
TCBI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3331382000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3331382000.00
TCBI cash_flow (annual, 2025-12-31) — Common Stock Payments: -185850000.00
TCBI cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -126616000.00
TCBI balance_sheet (annual, 2025-12-31) — Current Debt: 300000000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Current Debt: 300000000.00
TCBI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 300000000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 300000000.00
TCBI cash_flow (annual, 2025-12-31) — Deferred Income Tax: 15887000.00
TCBI cash_flow (annual, 2025-12-31) — Deferred Tax: 15887000.00
TCBI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 52166000.00
TCBI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 15875000.00
TCBI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 52166000.00
TCBI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 15875000.00
TCBI income_statement (annual, 2025-12-31) — Diluted Average Shares: 46127375.00
TCBI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 45509370.00
TCBI income_statement (annual, 2025-12-31) — Diluted EPS: 6.79
TCBI income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.12
TCBI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 312994000.00
TCBI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 96347000.00
TCBI cash_flow (annual, 2025-12-31) — End Cash Position: 2099118000.00
TCBI cash_flow (quarterly, 2025-12-31) — End Cash Position: 2099118000.00
TCBI cash_flow (annual, 2025-12-31) — Financing Cash Flow: 404269000.00
TCBI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1132364000.00
TCBI cash_flow (annual, 2025-12-31) — Free Cash Flow: 347585000.00
TCBI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 130835000.00
TCBI cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -5094000.00
TCBI cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -610000.00
TCBI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -1886000.00
TCBI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
TCBI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -64585000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -64585000.00
TCBI income_statement (annual, 2025-12-31) — General And Administrative Expense: 498413000.00
TCBI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 111127000.00
TCBI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1496000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1496000.00
TCBI balance_sheet (annual, 2025-12-31) — Gross PPE: 131688000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 131688000.00
TCBI balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 725722000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 725722000.00
TCBI cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 70178000.00
TCBI cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 2776000.00
TCBI income_statement (annual, 2025-12-31) — Insurance And Claims: 17911000.00
TCBI income_statement (quarterly, 2025-12-31) — Insurance And Claims: 2276000.00
TCBI income_statement (annual, 2025-12-31) — Interest Expense: 743148000.00
TCBI income_statement (quarterly, 2025-12-31) — Interest Expense: 176877000.00
TCBI income_statement (annual, 2025-12-31) — Interest Income: 1771785000.00
TCBI income_statement (quarterly, 2025-12-31) — Interest Income: 444314000.00
TCBI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 760112000.00
TCBI cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 179521000.00
TCBI balance_sheet (annual, 2025-12-31) — Invested Capital: 4251957000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 4251957000.00
TCBI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1854113000.00
TCBI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 36163000.00
TCBI balance_sheet (annual, 2025-12-31) — Investments And Advances: 4723099000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 4723099000.00
TCBI balance_sheet (annual, 2025-12-31) — Long Term Debt: 620575000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 620575000.00
TCBI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 620575000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 620575000.00
TCBI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -40435000.00
TCBI cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
TCBI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 50213000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 50213000.00
TCBI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -185850000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -126616000.00
TCBI income_statement (annual, 2025-12-31) — Net Income: 330244000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Income: 100659000.00
TCBI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 312994000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 96347000.00
TCBI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 330244000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 100659000.00
TCBI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 330244000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 100659000.00
TCBI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 330244000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 100659000.00
TCBI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 330244000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 100659000.00
TCBI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 330244000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 100659000.00
TCBI income_statement (annual, 2025-12-31) — Net Interest Income: 1028637000.00
TCBI income_statement (quarterly, 2025-12-31) — Net Interest Income: 267437000.00
TCBI cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -199818000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -100751000.00
TCBI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -595435000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 55000000.00
TCBI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -40435000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
TCBI balance_sheet (annual, 2025-12-31) — Net PPE: 88003000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Net PPE: 88003000.00
TCBI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -12569000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 341000.00
TCBI cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -555000000.00
TCBI cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 55000000.00
TCBI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3629886000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3629886000.00
TCBI income_statement (annual, 2025-12-31) — Normalized Income: 330244000.00
TCBI income_statement (quarterly, 2025-12-31) — Normalized Income: 100659000.00
TCBI income_statement (annual, 2025-12-31) — Occupancy And Equipment: 47619000.00
TCBI income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 12803000.00
TCBI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 360154000.00
TCBI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 130494000.00
TCBI cash_flow (annual, 2025-12-31) — Operating Gains Losses: -3208000.00
TCBI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -610000.00
TCBI income_statement (annual, 2025-12-31) — Operating Revenue: 1255779000.00
TCBI income_statement (quarterly, 2025-12-31) — Operating Revenue: 327483000.00
TCBI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 44253688.00
TCBI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 44253688.00
TCBI balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 300000000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 300000000.00
TCBI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -64585000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -64585000.00
TCBI income_statement (annual, 2025-12-31) — Other Non Interest Expense: 154476000.00
TCBI income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 43284000.00
TCBI balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
TCBI balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
TCBI balance_sheet (annual, 2025-12-31) — Payables: 6716000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Payables: 6716000.00
TCBI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6716000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6716000.00
TCBI balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 300000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 300000.00
TCBI balance_sheet (annual, 2025-12-31) — Preferred Stock: 300000000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 300000000.00
TCBI cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -17250000.00
TCBI cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -4312000.00
TCBI income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 17250000.00
TCBI income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 4312000.00
TCBI balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 300000000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 300000000.00
TCBI income_statement (annual, 2025-12-31) — Pretax Income: 432710000.00
TCBI income_statement (quarterly, 2025-12-31) — Pretax Income: 132285000.00
TCBI cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -7364000.00
TCBI cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 195000.00
TCBI income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 50112000.00
TCBI income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 11580000.00
TCBI balance_sheet (annual, 2025-12-31) — Properties: 81475000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Properties: 81475000.00
TCBI cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1136644000.00
TCBI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -293454000.00
TCBI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -12569000.00
TCBI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 341000.00
TCBI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 52166000.00
TCBI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 15875000.00
TCBI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -40435000.00
TCBI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
TCBI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -185850000.00
TCBI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -126616000.00
TCBI balance_sheet (annual, 2025-12-31) — Retained Earnings: 2808645000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2808645000.00
TCBI income_statement (annual, 2025-12-31) — Salaries And Wages: 480502000.00
TCBI income_statement (quarterly, 2025-12-31) — Salaries And Wages: 108851000.00
TCBI cash_flow (annual, 2025-12-31) — Sale Of Investment: 936826000.00
TCBI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 192703000.00
TCBI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 17449000.00
TCBI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 5404000.00
TCBI income_statement (annual, 2025-12-31) — Selling General And Administration: 515862000.00
TCBI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 116531000.00
TCBI balance_sheet (annual, 2025-12-31) — Share Issued: 51786456.00
TCBI balance_sheet (quarterly, 2025-12-31) — Share Issued: 51786456.00
TCBI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 36759000.00
TCBI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 8145000.00
TCBI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3631382000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3631382000.00
TCBI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3329886000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3329886000.00
TCBI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TCBI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TCBI income_statement (annual, 2025-12-31) — Tax Provision: 102466000.00
TCBI income_statement (quarterly, 2025-12-31) — Tax Provision: 31626000.00
TCBI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
TCBI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
TCBI balance_sheet (annual, 2025-12-31) — Total Assets: 31540274000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Total Assets: 31540274000.00
TCBI balance_sheet (annual, 2025-12-31) — Total Capitalization: 4251957000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 4251957000.00
TCBI balance_sheet (annual, 2025-12-31) — Total Debt: 920575000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Total Debt: 920575000.00
TCBI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3631382000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3631382000.00
TCBI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 27908892000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 27908892000.00
TCBI balance_sheet (annual, 2025-12-31) — Trading Securities: 3924000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Trading Securities: 3924000.00
TCBI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 7532768.00
TCBI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 7532768.00
TCBI balance_sheet (annual, 2025-12-31) — Treasury Stock: 487692000.00
TCBI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 487692000.00
TCBI income_statement (quarterly, 2026-03-31) — +Total Revenue: 323985000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 9420000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1077139000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3955879000.00
TCBI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 43971519.00
TCBI income_statement (quarterly, 2026-03-31) — Basic EPS: 1.58
TCBI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2099118000.00
TCBI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1357000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 300520000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2956611000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 2956611000.00
TCBI cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -4313000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Cash Financial: 254428000.00
TCBI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1911981000.00
TCBI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1142017000.00
TCBI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 87529000.00
TCBI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -43059000.00
TCBI cash_flow (quarterly, 2026-03-31) — Change In Payable: -43059000.00
TCBI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -43059000.00
TCBI cash_flow (quarterly, 2026-03-31) — Change In Receivables: 16089000.00
TCBI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -26970000.00
TCBI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 16089000.00
TCBI cash_flow (quarterly, 2026-03-31) — Changes In Cash: 857493000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Common Stock: 520000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3306207000.00
TCBI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -75141000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
TCBI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
TCBI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 12816000.00
TCBI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 12816000.00
TCBI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 44601129.00
TCBI income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.56
TCBI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 69475000.00
TCBI cash_flow (quarterly, 2026-03-31) — End Cash Position: 2956611000.00
TCBI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1911981000.00
TCBI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 86172000.00
TCBI cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -5604000.00
TCBI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 0.00
TCBI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -86739000.00
TCBI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 144224000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1496000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 709594000.00
TCBI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1620000.00
TCBI income_statement (quarterly, 2026-03-31) — Insurance And Claims: 4877000.00
TCBI income_statement (quarterly, 2026-03-31) — Interest Expense: 164375000.00
TCBI income_statement (quarterly, 2026-03-31) — Interest Income: 419094000.00
TCBI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 180511000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4184500000.00
TCBI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1142017000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 4673355000.00
TCBI cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 397599000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 878293000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 878293000.00
TCBI cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 397599000.00
TCBI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -134525000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -75141000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Income: 73788000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 69475000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 73788000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 73788000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 73788000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 73788000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 73788000.00
TCBI income_statement (quarterly, 2026-03-31) — Net Interest Income: 254719000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 37491000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -66926000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 263074000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Net PPE: 85698000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1357000.00
TCBI cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -330000000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3604711000.00
TCBI income_statement (quarterly, 2026-03-31) — Normalized Income: 73788000.00
TCBI income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 12405000.00
TCBI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 87529000.00
TCBI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -5604000.00
TCBI income_statement (quarterly, 2026-03-31) — Operating Revenue: 323985000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 43671305.00
TCBI balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 0.00
TCBI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -86739000.00
TCBI income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 39987000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 0.00
TCBI balance_sheet (quarterly, 2026-03-31) — Payables: 9420000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 9420000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 300000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 300000000.00
TCBI cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -4313000.00
TCBI income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 4313000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 300000000.00
TCBI income_statement (quarterly, 2026-03-31) — Pretax Income: 94417000.00
TCBI cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -9560000.00
TCBI income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 11980000.00
TCBI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -134520000.00
TCBI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1357000.00
TCBI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 12816000.00
TCBI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -134525000.00
TCBI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -75141000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2878120000.00
TCBI income_statement (quarterly, 2026-03-31) — Salaries And Wages: 139347000.00
TCBI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 172011000.00
TCBI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 4972000.00
TCBI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 149196000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Share Issued: 51974496.00
TCBI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 17499000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3606207000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3304711000.00
TCBI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TCBI income_statement (quarterly, 2026-03-31) — Tax Provision: 20629000.00
TCBI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
TCBI balance_sheet (quarterly, 2026-03-31) — Total Assets: 33486484000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4484500000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Total Debt: 878293000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3606207000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 29880277000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Trading Securities: 7882000.00
TCBI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 8303191.00
TCBI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 562833000.00
TCBI income_statement (quarterly, 2026-06-30) — Basic Average Shares: 43587027.00
TCBI income_statement (quarterly, 2026-06-30) — Basic EPS: 1.85
TCBI income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 44062419.00
TCBI income_statement (quarterly, 2026-06-30) — Diluted EPS: 1.83
TCBIO balance_sheet (annual, 2021-12-31) — Accounts Receivable: 559897000.00
TCBIO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
TCBIO income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
TCBIO balance_sheet (annual, 2021-12-31) — Goodwill: 15094000.00
TCBIO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 289723000.00
TCBIO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 639440000.00
TCBIO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 639440000.00
TCBIO cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
TCBIO cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 115891000.00
TCBIO cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 528440000.00
TCBIO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -3121000.00
TCBIO cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 139723000.00
TCBIO income_statement (annual, 2021-12-31) — Other Gand A: 75185000.00
TCBIO balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 2168000.00
TCBIO cash_flow (annual, 2021-12-31) — Other Non Cash Items: 246254000.00
TCBIO cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 289723000.00
TCBIO cash_flow (annual, 2021-12-31) — Preferred Stock Payments: -150000000.00
TCBIO balance_sheet (annual, 2021-12-31) — Receivables: 559897000.00
TCBIO income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
TCBIO cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
TCBIO cash_flow (annual, 2021-12-31) — Sale Of Intangibles: 115891000.00
TCBIO income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
TCBIO income_statement (annual, 2021-12-31) — Total Unusual Items: 0.00
TCBIO income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TCBIO income_statement (annual, 2022-12-31) — +Total Revenue: 976761000.00
TCBIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 24000000.00
TCBIO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 719162000.00
TCBIO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -63129000.00
TCBIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1025593000.00
TCBIO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 33956000.00
TCBIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 7946659000.00
TCBIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -11270000.00
TCBIO balance_sheet (annual, 2022-12-31) — Capital Stock: 300509000.00
TCBIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 5012260000.00
TCBIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 5012260000.00
TCBIO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -17250000.00
TCBIO balance_sheet (annual, 2022-12-31) — Cash Financial: 233637000.00
TCBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -6390936000.00
TCBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 3308567000.00
TCBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 147970000.00
TCBIO cash_flow (annual, 2022-12-31) — Change In Account Payable: 2518000.00
TCBIO cash_flow (annual, 2022-12-31) — Change In Payable: 2518000.00
TCBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 2518000.00
TCBIO cash_flow (annual, 2022-12-31) — Change In Receivables: -25482000.00
TCBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: -22964000.00
TCBIO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -25482000.00
TCBIO cash_flow (annual, 2022-12-31) — Changes In Cash: -2934399000.00
TCBIO balance_sheet (annual, 2022-12-31) — Common Stock: 509000.00
TCBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2755351000.00
TCBIO cash_flow (annual, 2022-12-31) — Common Stock Payments: -115302000.00
TCBIO balance_sheet (annual, 2022-12-31) — Current Debt: 1200000000.00
TCBIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1200000000.00
TCBIO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -17395000.00
TCBIO cash_flow (annual, 2022-12-31) — Deferred Tax: -17395000.00
TCBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 45284000.00
TCBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 45284000.00
TCBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 315228000.00
TCBIO cash_flow (annual, 2022-12-31) — End Cash Position: 5012260000.00
TCBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -6390936000.00
TCBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: 136700000.00
TCBIO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -248526000.00
TCBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 248526000.00
TCBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 0.00
TCBIO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -418943000.00
TCBIO income_statement (annual, 2022-12-31) — General And Administrative Expense: 449250000.00
TCBIO balance_sheet (annual, 2022-12-31) — Goodwill: 1496000.00
TCBIO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1496000.00
TCBIO balance_sheet (annual, 2022-12-31) — Gross PPE: 89511000.00
TCBIO balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 935514000.00
TCBIO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 128435000.00
TCBIO income_statement (annual, 2022-12-31) — Insurance And Claims: 14344000.00
TCBIO income_statement (annual, 2022-12-31) — Interest Expense: 268479000.00
TCBIO income_statement (annual, 2022-12-31) — Interest Income: 1144244000.00
TCBIO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 252178000.00
TCBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 4886793000.00
TCBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: 3308567000.00
TCBIO balance_sheet (annual, 2022-12-31) — Investments And Advances: 3585114000.00
TCBIO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
TCBIO balance_sheet (annual, 2022-12-31) — Long Term Debt: 931442000.00
TCBIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 931442000.00
TCBIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
TCBIO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 54581000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 3324159000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -115302000.00
TCBIO income_statement (annual, 2022-12-31) — Net Income: 332478000.00
TCBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 315228000.00
TCBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 332478000.00
TCBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 332478000.00
TCBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 332478000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 332478000.00
TCBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 332478000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
TCBIO income_statement (annual, 2022-12-31) — Net Interest Income: 875765000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -388446000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1001690000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4209000.00
TCBIO balance_sheet (annual, 2022-12-31) — Net PPE: 26382000.00
TCBIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -11270000.00
TCBIO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -1001690000.00
TCBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3053855000.00
TCBIO income_statement (annual, 2022-12-31) — Normalized Income: 141112980.00
TCBIO income_statement (annual, 2022-12-31) — Occupancy And Equipment: 44222000.00
TCBIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 147970000.00
TCBIO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -247536000.00
TCBIO income_statement (annual, 2022-12-31) — Operating Revenue: 976761000.00
TCBIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 48783763.00
TCBIO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1200000000.00
TCBIO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -418943000.00
TCBIO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -29329000.00
TCBIO income_statement (annual, 2022-12-31) — Other Non Interest Expense: 125814000.00
TCBIO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 2615644000.00
TCBIO balance_sheet (annual, 2022-12-31) — Payables: 24000000.00
TCBIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 24000000.00
TCBIO balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 300000.00
TCBIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 300000000.00
TCBIO cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -17250000.00
TCBIO income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 17250000.00
TCBIO balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 300000000.00
TCBIO cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
TCBIO income_statement (annual, 2022-12-31) — Pretax Income: 431755000.00
TCBIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -4209000.00
TCBIO income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 75858000.00
TCBIO balance_sheet (annual, 2022-12-31) — Properties: 34930000.00
TCBIO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -920217000.00
TCBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -11270000.00
TCBIO balance_sheet (annual, 2022-12-31) — Receivables: 719162000.00
TCBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 45284000.00
TCBIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -115302000.00
TCBIO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
TCBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: 2263502000.00
TCBIO income_statement (annual, 2022-12-31) — Salaries And Wages: 434906000.00
TCBIO cash_flow (annual, 2022-12-31) — Sale Of Business: 3324159000.00
TCBIO cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 0.00
TCBIO cash_flow (annual, 2022-12-31) — Sale Of Investment: 531771000.00
TCBIO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 32388000.00
TCBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 481638000.00
TCBIO balance_sheet (annual, 2022-12-31) — Share Issued: 50867298.00
TCBIO income_statement (annual, 2022-12-31) — Special Income Charges: 248526000.00
TCBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 21432000.00
TCBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3055351000.00
TCBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2753855000.00
TCBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 57160980.00
TCBIO income_statement (annual, 2022-12-31) — Tax Provision: 99277000.00
TCBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
TCBIO balance_sheet (annual, 2022-12-31) — Total Assets: 28414642000.00
TCBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 3986793000.00
TCBIO balance_sheet (annual, 2022-12-31) — Total Debt: 2131442000.00
TCBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3055351000.00
TCBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 25359291000.00
TCBIO income_statement (annual, 2022-12-31) — Total Unusual Items: 248526000.00
TCBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 248526000.00
TCBIO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2083535.00
TCBIO balance_sheet (annual, 2022-12-31) — Treasury Stock: 115310000.00
TCBIO income_statement (annual, 2023-12-31) — +Total Revenue: 1075542000.00
TCBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 33234000.00
TCBIO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 801670000.00
TCBIO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -70548000.00
TCBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1045576000.00
TCBIO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 51825000.00
TCBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 5012260000.00
TCBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -16381000.00
TCBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 300511000.00
TCBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3242850000.00
TCBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 3242850000.00
TCBIO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -17250000.00
TCBIO balance_sheet (annual, 2023-12-31) — Cash Financial: 200493000.00
TCBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -387672000.00
TCBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1755478000.00